Udo EO, Zuithoff NPA, Van Hemel NM, De Cock CC, Hendriks T, Doevendans PA, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: The FOLLOWPACE study. Heart Rhythm. 2012;9(5):728–35.
Frausing MHJP, Kronborg MB, Johansen JB, Nielsen JC. Avoiding implant complications in cardiac implantable electronic devices: what works? EP Eur. 2021;23(2):163–73.
Xu F, Meng L, Lin H, Xu W, Guo H, Peng F. Systematic review of leadless pacemaker. Acta Cardiol. 2023;14:1–11.
Duray GZ, Ritter P, El-Chami M, Narasimhan C, Omar R, Tolosana JM, et al. Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. Heart Rhythm. 2017;14(5):702–9.
El-Chami MF, Al-Samadi F, Clementy N, Garweg C, Martinez-Sande JL, Piccini JP, et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control. Heart Rhythm. 2018;15(12):1800–7.
Piccini JP, El-Chami M, Wherry K, Crossley GH, Kowal RC, Stromberg K, et al. Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker. JAMA Cardiol. 2021;6(10):1187.
Shtembari J, Shrestha DB, Awal S, Raut A, Gyawali P, Abe T, et al. Comparative assessment of safety with leadless pacemakers compared to transvenous pacemakers: a systemic review and meta-analysis. J Interv Card Electrophysiol. 2023;66(9):2165–75.
Darlington D, Brown P, Carvalho V, Bourne H, Mayer J, Jones N, et al. Efficacy and safety of leadless pacemaker: A systematic review, pooled analysis and meta-analysis. Indian Pacing Electrophysiol J. 2022;22(2):77–86.
Alhuarrat MAD, Kharawala A, Renjithlal S, MagdiEid M, Varrias D, Mohammed M, et al. Comparison of in-hospital outcomes and complications of leadless pacemaker and traditional transvenous pacemaker implantation. Europace. 2023;25(9):euad269.
Article PubMed PubMed Central Google Scholar
Crossley GH, Piccini JP, Longacre C, Higuera L, Stromberg K, El-Chami MF. Leadless versus transvenous single-chamber ventricular pacemakers: 3 year follow-up of the Micra CED study. J Cardiovasc Electrophysiol. 2023;34(4):1015–23.
Mararenko A, Udongwo N, Pannu V, Miller B, Alshami A, Ajam F, et al. Intracardiac leadless versus transvenous permanent pacemaker implantation: Impact on clinical outcomes and healthcare utilization. J Cardiol. 2023;82(5):378–87.
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29:n71.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;12:i4919.
Reynolds D, Duray GZ, Omar R, Soejima K, Neuzil P, Zhang S, et al. A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med. 2016;374(6):533–41.
Article CAS PubMed Google Scholar
Bodin A, Clementy N, Bisson A, Pierre B, Herbert J, Babuty D, et al. Leadless or Conventional Transvenous Ventricular Permanent Pacemakers: A Nationwide Matched Control Study. J Am Heart Assoc. 2022;11(16):e025339.
Article PubMed PubMed Central Google Scholar
Bertelli M, Toniolo S, Ziacchi M, Gasperetti A, Schiavone M, Arosio R, et al. Is Less Always More? A Prospective Two-Centre Study Addressing Clinical Outcomes in Leadless versus Transvenous Single-Chamber Pacemaker Recipients. J Clin Med. 2022;11(20):6071.
Article PubMed PubMed Central Google Scholar
Beurskens NEG, Tjong FVY, De Bruin-Bon RHA, Dasselaar KJ, Kuijt WJ, Wilde AAM, et al. Impact of Leadless Pacemaker Therapy on Cardiac and Atrioventricular Valve Function Through 12 Months of Follow-Up. Circ Arrhythm Electrophysiol. 2019;12(5):e007124.
Cabanas-Grandío P, García Campo E, Bisbal F, García-Seara J, Pachón M, Juan-Salvadores P, et al. Quality of life of patients undergoing conventional vs leadless pacemaker implantation: A multicenter observational study. J Cardiovasc Electrophysiol. 2020;31(1):330–6.
Cantillon DJ, Dukkipati SR, Ip JH, Exner DV, Niazi IK, Banker RS, et al. Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers. Heart Rhythm. 2018;15(7):1023–30.
Martinez Sande JL, Garcia-Seara J, Gonzalez-Melchor L, Rodriguez-Manero M, Torrelles-Fortuny A, Perez-Poza M, et al. Leadless pacemaker implant with concomitant atrioventricular node ablation: A single center study with long term follow up. Europace. 2021;23(SUPPL 3):iii428.
Moore SKL, Chau KH, Chaudhary S, Rubin G, Bayne J, Avula UMR, et al. Leadless pacemaker implantation: A feasible and reasonable option in transcatheter heart valve replacement patients. Pacing Clin Electrophysiol. 2019;42(5):542–7.
Article PubMed PubMed Central Google Scholar
Pagan E, Gabriels J, Khodak A, Chang D, Beldner S, Epstein LM, et al. Safety of leadless pacemaker implantation in the very elderly. Heart Rhythm. 2020;17(12):2023–8.
Palmisano P, Facchin D, Ziacchi M, Nigro G, Nicosia A, Bongiorni MG, et al. Rate and nature of complications with leadless transcatheter pacemakers compared with transvenous pacemakers: results from an Italian multicentre large population analysis. EP Eur. 2023;25(1):112–20.
Sanchez R, Nadkarni A, Buck B, Daoud G, Koppert T, Okabe T, et al. Incidence of pacing-induced cardiomyopathy in pacemaker-dependent patients is lower with leadless pacemakers compared to transvenous pacemakers. J Cardiovasc Electrophysiol. 2021;32(2):477–83.
Sasaki K, Togashi D, Nakajima I, Suchi T, Nakayama Y, Harada T, et al. Clinical Outcomes of Non-Atrial Fibrillation Bradyarrhythmias Treated With a Ventricular Demand Leadless Pacemaker Compared With an Atrioventricular Synchronous Transvenous Pacemaker - A Propensity Score-Matched Analysis -. Circ J. 2022;86(8):1283–91.
Tachibana M, Banba K, Matsumoto K, Ohara M. The feasibility of leadless pacemaker implantation for superelderly patients. Pacing Clin Electrophysiol. 2020;43(4):374–81.
Tjong FVY, Knops RE, Udo EO, Brouwer TF, Dukkipati SR, Koruth JS, et al. Leadless pacemaker versus transvenous single-chamber pacemaker therapy: A propensity score-matched analysis. Heart Rhythm. 2018;15(9):1387–93.
Vaidya VR, Dai M, Asirvatham SJ, Rea RF, Thome TM, Srivathsan K, et al. Real-world experience with leadless cardiac pacing. Pacing Clin Electrophysiol. 2019;42(3):366–73.
Yarlagadda B, Turagam MK, Dar T, Janagam P, Veerapaneni V, Atkins D, et al. Safety and feasibility of leadless pacemaker in patients undergoing atrioventricular node ablation for atrial fibrillation. Heart Rhythm. 2018;15(7):994–1000.
Zucchelli G, Tolve S, Barletta V, Di Cori A, Parollo M, De Lucia R, et al. Comparison between leadless and transvenous single-chamber pacemaker therapy in a referral centre for lead extraction. J Interv Card Electrophysiol. 2021;61(2):395–404.
Okuyama K, Izumo M, Sasaki K, Kuwata S, Kaihara T, Watanabe M, Koga M, Kamijima R, Takano M, Ishibashi Y, Tanabe Y, Higuma T, Harada T, Akashi YJ. Comparison in Clinical Outcomes Between Leadless and Conventional Transvenous Pacemaker Following Transcatheter Aortic Valve Implantation. J Invasive Cardiol. 2020;32(10):400–4 (PMID: 32999094).
Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42(35):3427–520.
El-Chami MF, Bonner M, Holbrook R, Stromberg K, Mayotte J, Molan A, et al. Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms. Heart Rhythm. 2020;17(8):1393–7.
El-Chami MF, Garweg C, Clementy N, Al-Samadi F, Iacopino S, Martinez-Sande JL, et al. Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry. Eur Heart J. 2024;1:ehae101 The Micra leadless pacemaker has consistently shown favorable long-term outcomes, characterized by minimal occurrences of significant problems and system changes, as well as an exceptionally low risk of infection.
Wijesuriya N, Elliott MK, Mehta V, Sidhu BS, Behar JM, Niederer S, et al. Leadless left ventricular endocardial pacing for cardiac resynchronization therapy: A systematic review and meta-analysis. Heart Rhythm. 2022;19(7):1176–83.
留言 (0)